GYY4137: A New Hydrogen Sulfide Donor with Anti-Cancer Effects
Author Information
Author(s): Lee Zheng Wei, Zhou Jianbiao, Chen Chien-Shing, Zhao Yujun, Tan Choon-Hong, Li Ling, Moore Philip Keith, Deng Lih-Wen
Primary Institution: National University of Singapore
Hypothesis
Does the slow-releasing hydrogen sulfide donor GYY4137 exhibit anti-cancer effects in vitro and in vivo?
Conclusion
GYY4137 shows significant anti-cancer activity by releasing hydrogen sulfide over several days, leading to cancer cell death without affecting normal cells.
Supporting Evidence
- GYY4137 caused concentration-dependent killing of seven different human cancer cell lines.
- GYY4137 did not affect the survival of normal human lung fibroblasts.
- Xenograft studies showed that GYY4137 significantly reduced tumor growth in mice.
Takeaway
GYY4137 is a special medicine that helps kill cancer cells while leaving normal cells alone by slowly releasing a gas called hydrogen sulfide.
Methodology
The study involved in vitro tests on cancer cell lines and in vivo tests using mice with cancer, measuring cell survival and tumor growth.
Potential Biases
Potential bias in the selection of cell lines and the experimental conditions used.
Limitations
The study primarily focused on specific cancer cell lines and may not represent all types of cancer.
Participant Demographics
The study used human cancer cell lines and immunodeficient mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website